Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page
- Check6 days agoChange DetectedRemoved the MedlinePlus Genetics topic on Type 2 diabetes, narrowing the genetics topics covered on the page.SummaryDifference0.3%

- Check13 days agoNo Change Detected
- Check20 days agoChange Detected- Updated version from v3.1.0 to v3.2.0 and added a government operation status notice and a new MedlinePlus Genetics topic on Type 2 diabetes. The previous v3.1.0 reference was removed.SummaryDifference4%

- Check28 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check35 days agoChange DetectedRemoved a MedlinePlus Genetics topic: Type 2 diabetes.SummaryDifference0.3%

- Check42 days agoChange DetectedVersion bump from v3.0.1 to v3.0.2; removal of the 'Back to Top' element. Overall, a minor maintenance update with no substantive core-content changes.SummaryDifference0.2%

- Check49 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.